Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 656

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles

Open access
Hanley, Cory, Layne, Janet, Punnoose, Alex, Reddy, K M, Coombs, Isaac, Coombs, Andrew, Feris, Kevin, Wingett, Denise·2008·Nanotechnology

Abstract

Nanoparticles are increasingly being recognized for their potential utility in biological applications including nanomedicine. Here we examine the response of normal human cells to ZnO nanoparticles under different signaling environments and compare it to the response of cancerous cells. ZnO nanoparticles exhibit a strong preferential ability to kill cancerous T cells ( approximately 28-35x) compared to normal cells. Interestingly, the activation state of the cell contributes toward nanoparticle toxicity, as resting T cells display a relative resistance while cells stimulated through the T cell receptor and CD28 costimulatory pathway show greater toxicity in direct relation to the level of activation. Mechanisms of toxicity appear to involve the generation of reactive oxygen species, with cancerous T cells producing higher inducible levels than normal T cells. In addition, nanoparticles were found to induce apoptosis and the inhibition of reactive oxygen species was found to be protective against nanoparticle induced cell death. The novel findings of cell selective toxicity, towards potential disease causing cells, indicate a potential utility of ZnO nanoparticles in the treatment of cancer and/or autoimmunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1088/0957-4484/19/29/295103

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 656

Metadata

Authors
Hanley, C., Layne, J., Punnoose, A., Reddy, K. M., Coombs, I., Coombs, A., Feris, K., & Wingett, D.
Venue
Nanotechnology
Published
2008-06-10
Volume
19
Issue
29
Pages
295103
ISSN
  • 0957-4484 (ISSN-L)
  • 1361-6528
OpenAlex
W3142110808
Cited by
656
References
25
FWCI
8.76
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. https://app.cochat.ai/papers/10.1088/0957-4484/19/29/295103
The paper
Hanley, C., Layne, J., Punnoose, A., Reddy, K. M., Coombs, I., Coombs, A., Feris, K., & Wingett, D. (2008). Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Nanotechnology. https://doi.org/10.1088/0957-4484/19/29/295103

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.